Ann: Botanix $40 Million US Lead Placement and Management Update, page-99

I agree that it's still early to determine the impact of the release, however, this CR should be seen as an enabler rather than something sinister. It's literally provided the means to fast track all trials and subsequent associated tasks. The breaks are literally off and we can expect many great things. Adding to that, a steady increase in the SP could also see less willing to sell out and see what the near term brings. Assuming that come to pass, we could be seeing $0.30 rather than the issue price.

i myself have been busy hoovering up these last two days and sit on a decent amount now. I'm very much looking forward to the remainder of 2019. Thank you greatly to those who sold out yesterday